Inhibition of reverse transcriptase of human immunodeficiency virus type 1 and chimeric enzymes of human immunodeficiency viruses types 1 and 2 by two novel non-nucleoside inhibitors-Reference-Cited by-同舟云学术

Inhibition of reverse transcriptase of human immunodeficiency virus type 1 and chimeric enzymes of human immunodeficiency viruses types 1 and 2 by two novel non-nucleoside inhibitors

Published:1994-08-22 Issue:2-3 Volume:350 Page:299-303
ISSN:0014-5793
Container-title:FEBS Letters
language:en
Short-container-title:

Author:

Rubinek Tami,McMahon James B.,Hizi Amnon

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/0014-5793(94)00793-4/fullpdf

Reference25 articles.

1. Reverse transcriptases from human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus (SIVMAC) are susceptible to inhibition by foscarnet and 3'-azido-3'-deoxythymidine triphosphate

2. Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor

3. Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity.

4. Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

5. Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis and biological evaluation of quinoxaline compounds as anti-HIV agents targeting reverse transcriptase enzyme;European Journal of Medicinal Chemistry;2020-02

2. Retroviral reverse transcriptases (other than those of HIV-1 and murine leukemia virus): A comparison of their molecular and biochemical properties;Virus Research;2008-06

3. Hierarchical Strategy for Identifying Active Chemotype Classes in Compound Databases;Chemical Biology & Drug Design;2006-06

4. Therapeutic innovations against HIV;Expert Opinion on Therapeutic Patents;2006-02-28

5. Évaluation de l'efficacité et de la tolérance du traitement antirétroviral chez des patients infectés par le VIH-2 à Dakar : étude préliminaire;Médecine et Maladies Infectieuses;2006-02